Mediation of interleukin-1β - Induced transforming growth factor β1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes possible cooperation with activator protein 1

Arthritis and Rheumatism

Volumn 48, Issue 6, 2003, Pages 1569-1581

  Andriamanalijaona, R ^a   Felisaz, N ^a   Kim, S J ^b   King Jones, K ^c   Lehmann, M ^c   Pujol, J P ^a,d   Boumediene, K ^a  

^a Lab of Connective Tissue Biochem   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECOMBINANT INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 4; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ENHANCER BINDING PROTEIN AP 4; ENHANCER-BINDING PROTEIN AP-4; INTERLEUKIN 1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BIOSYNTHESIS; BONE MALFORMATION; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CATABOLISM; CATTLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; GENE CONSTRUCT; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STEADY STATE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; ARTICULAR CARTILAGE; CHEMISTRY; CYTOLOGY; DNA SEQUENCE; DOSE RESPONSE; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BASE SEQUENCE; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; CHONDROCYTES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0038313096     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11020     Document Type: Article

References (47)

1. Pujol J-P, Loyau G. Interleukin-1 and osteoarthritis. Life Sci 1987;41:1187-98.
2. Pelletier JP, Martel-Pelletier J. Evidence for the involvement of interleukin-1 in human osteoarthritic cartilage degradation: protective effect of NSAID. J Rheumatol 1989;16:19-27.
3. Howell DS. Pathogenesis of osteoarthritis. Am J Med 1986;80:24-8.
4. Hamerman D. The biology of osteoarthritis. N Engl J Med 1989;320:1322-30.
5. Mankin HJ. Reaction of articular cartilage to injury and osteoarthritis. N Engl J Med 1974;291:1310-35.
6. Vignon E, Arlot M, Hartmann D, Moyen B, Ville G. Hypertrophic repair of articular cartilage in experimental osteoarthritis. Ann Rheum Dis 1983;42:82-8.
7. Brandt K. Transection of the anterior cruciate ligament in the dog: a model of osteoarthritis. Semin Arthritis Rheum 1991;21:22-32.
8. Seyedin SM, Thomas TC, Thompson AY, Rosen DM, Piez KA. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci U S A 1985;82:2267-71.
9. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-beta: biological function and chemical structure. Science 1986;233:532-4.
10. Elford PR, Graeber M, Ohtsu H, Aeberhard M, Legendre B, Wishart WL, et al. Induction of swelling, synovial hyperplasia and cartilage proteoglycan loss upon intra-articular injection of transforming growth factor-beta 2 in the rabbit. Cytokine 1992;4:232-8.
11. Massagué J, Cheifetz S, Laiho M, Ralph DA, Weis FMB, Zentella A. Transforming growth factor-beta. Cancer Surv 1992;12:81-103.
12. Hunziker EB. Growth-factor-induced healing of partial-thickness defects in adult cartilage. Osteoarthritis Cart 2001;9:22-32.
13. Rédini F, Mauviel A, Pronost S, Loyau G, Pujol J-P. Transforming growth factor βexerts opposite effects from interleukin-1β on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1993;36:44-50.
14. Pujol J-P, Galéra P, Pronost S, Boumediene K, Vivien D, Macro M, et al. Transforming growth factor-β (TGF-β and articular chondrocytes. Ann Endocrinol 1994;55:109-20.
15. Boumediene K, Conrozier T, Mathieu P, Richard M, Marcelli C, Vignon E, et al. Decrease of cartilage TGF-β receptor II expression in the rabbit experimental osteoarthritis: potential role in cartilage breakdown. Osteoarthritis Cart 1998;6:146-9.
16. Pujol J-P. TGF-β and osteoarthritis: in vivo veritas. Osteoarthritis Cart 1999;7:439-40.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
18. -ΔΔCT method. Methods 2001;25:402-8.
19. Kim SJ, Glick A, Sporn MB, Roberts AB. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem 1989;264:402-8.
20. Sambrook J, Fritsh EF, Maniatis T. Expression of cloned genes in cultured mammalian cells. In: Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor: Laboratory Press; 1989. p. 16-30.
21. King-Jones K, Korge G, Lehmann M. The helix-loop-helix proteins dAP-4 and Daughterless bind both in vitro and in vivo to SEBP3 sites required for transcriptional activation of the Drosophila gene Sgs-4. J Mol Biol 1999;291:71-82.
22. Quandt K, Frech K, Karas H, Wingentder E, Werner T. Matlnd MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995;23:4878-84.
23. Wingender E, Kel AE, Kel OV, Karas H, Heinemeyer T, Dietze P, et al. TRANSFAC, TRRD and COMPEL: towards a federated database system on transcriptional regulation. Nucleic Acids Res 1997;25:265-8.
24. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucl Acids Res 1998;26:362-7.
25. Noma T, Glick AB, Geiser AG, O'Reilly MA, Miller J, Roberts AB, et al. Molecular cloning and structure of the human transforming growth factor-β2 gene promoter. Growth Factors 1991;4:247-55.
26. Lafyatis R, Lechleider R, Kim SJ, Jakowlew S, Roberts AB, Sporn MB. Structural and functional characterization of the transforming growth factor beta 3 promoter: a cAMP-responsive element regulates basal and induced transcription. J Biol Chem 1990;265:19128-36.
27. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, et al. Autoinduction by transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 1990;10:1492-7.
28. Kraus VB. Pathogenesis and treatment of osteoarthritis. Med Clin North Am 1997;81:85-112.
29. Villiger PM, Kusari AB, ten Dijke P, Lotz M. IL-1β and IL-6 selectively induce transforming growth factor-β isoforms in human articular chondrocytes. J Immunol 1993;1516:3337-43.
30. Yue TL, Wang XK, Olson B, Feurstein G. Interleukin-1β (IL-1β) induces transforming growth factor-β1 (TGF-β1) production by rat aortic smooth muscle cells. Biochem Biophys Res Commun 1994;204:1186-92.
31. Phan SH, Gharaee-Kermani M, McGarry B, Kunkel SL, Wolber FW. Regulation of rat pulmonary artery endothelial cell transforming growth factor-β production by IL-1β and tumor necrosis factor-α. J Immunol 1992;149:103-6.
32. Lo YTC, Conquer JA, Grinstein S, Cruz TF. Interleukin-1β induction of c-fos and collagenase expression in articular chondrocytes: involvement of reactive oxygen species. J Cell Biochem 1998;69:19-29.
33. Mermod N, Williams TJ, Tjian R. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 1988;332:557-61.
34. Hu YF, Luscher B, Admon A, Mermod N, Tjian R. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev 1990;4:1741-52.
35. Edmonson DG, Olson EN. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev 1989;3:628-40.
36. Lassar AB, Buskin JN, Lockshon D, Davis RL, Apone S, Hauschka SD, et al. MyoD is a sequence-specific DNA binding protein requiring a region of myc homolog to bind to the muscle creatine kinase enhancer. Cell 1989;58:823-31.
37. Ludwig SR, Habera LF, Dellaporta SL, Wessler SR. Lc, a member of the maize R gene family responsible for tissue-specific anthocyanin production, encodes a protein similar to transcriptional activators and contains the myc-homology region. Proc Natl Acad Sci 1989;86:7092-6.
38. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, Daughterless, MyoD, and myc proteins. Cell 1989;56:777-83.
39. Murre C, McCaw S, Vassin H, Caudy M, Jan LY, Jan YN, et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 1989;58:537-44.
40. Chiu R, Angel P, Karin M. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 1989;59:979-86.
41. Deng T, Karin M. JunB differs from c-Jun in its DNA binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev 1993;7:479-90.
42. Hou YT, Coleman TA, Kopchick JJ. AP-4- and AP-5-like proteins from mouse L cells are trans-activators and bind to the GT-II region of SV40 early TRE in a mutually exclusive manner. Gene 1995;162:197-203.
43. Comb M, Mermod N, Hyman SE, Pearlberg J, Ross ME, Goodman HM. Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription. EMBO J 1988;7:3793-805.
44. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Kellner JR. Transforming growth factor-β is a potent inhibitor of interleukin-1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J Exp Med 1990;172:734-44.
45. Pronost S, Segond N, Macro M, Rédini F, Penfornis H, Julienne A, et al. Modulation of interleukin-1 receptor expression by transforming growth factor-β: analysis by reverse transcription-polymerase chain reaction. Osteoarthritis Cartilage 1995;3:147-55.
46. Turber M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β. Eur J Immunol 1991;21:1635-9.
47. Lafeber FPJG, van der Kraan PM, Huber-Bruning O, van den Berg WB, Bijlsma JWJ. Osteoarthritic human cartilage is more sensitive to transforming growth factor-β than normal cartilage. Br J Rheumatol 1993;32:281-6.